Study links ultra-processed foods to cancer signals!
Digest more
Everyday Health on MSN
GLP-1 Drugs Like Ozempic May Boost Colon Cancer Survival
People with colon cancer who took GLP-1 drugs were less likely to die within 5 years than people not on GLP-1s, a new study finds.
Over the 24-year follow-up period, researchers identified 1,189 participants who developed early-onset adenomas and 1,598 with serrated lesions — two types of precancerous colon
GLP-1 drugs such as Ozempic and Wegovy may extend the lives of colon cancer patients, according to a major UC San Diego study. Patients on the medications had less than half the mortality rate of non-users.
“You’re young. You’re healthy. We’re not worried about cancer.” Those words echoed in doctor’s offices 2,500 miles apart. Sarah Beran heard them in Los Angeles when she mentioned blood in her stool. Brooks Bell received the same response in ...